The administration of adenoviral vectors designed for expression of decorin, which is an inhibitor of TGF-β1, was found to inhibit expression levels of TGF-β1 mRNA and protein and reduce fibrosis in the kidney of a rat model of diabetic nephropathy [37]. This evidence concerns the gene TGFB1 and diabetic kidney disease.